Logo image
TREATMENT UTILIZATION AND ASSOCIATED FACTORS IN PATIENTS WITH PRIMARY ADVANCED OR FIRST RECURRENT ENDOMETRIAL CANCER AFTER IMMUNOTHERAPY COMBINATION APPROVAL IN THE UNITED STATES
Journal article   Peer reviewed

TREATMENT UTILIZATION AND ASSOCIATED FACTORS IN PATIENTS WITH PRIMARY ADVANCED OR FIRST RECURRENT ENDOMETRIAL CANCER AFTER IMMUNOTHERAPY COMBINATION APPROVAL IN THE UNITED STATES

Leslie M. Randall, Solomon Lubinga, Qin Shen, Jean Hurteau, Magdalena Zajac, Ramya Peter, Matthias Hunger, Jaya Paranilam and John Farley
International journal of gynecological cancer, Vol.36(10), p.105430
10/2026

Metrics

2 Record Views

Details

Logo image